LifeArc: Philanthropic Fund and Seed Fund

LifeArc are committing £30m of funding to progress promising medical research.

**PLEASE NOTE ALL DATES ARE ESTIMATES UNTIL FURTHER INFORMATION IS LAUNCHED IN 2018**

Two new funds will invest in proof of concept opportunities or where commercial returns may be low.

The Philanthropic Fund provides grants for academic research funded by other medical research charities and organisations.

The Seed Fund invests in promising early stage therapeutics and biological research.

The funds will be launched at the beginning of 2018 and further details on the application process will be disclosed nearer the time.  

LifeArc are committing £30m of funding to progress promising medical research.

**PLEASE NOTE ALL DATES ARE ESTIMATES UNTIL FURTHER INFORMATION IS LAUNCHED IN 2018**

Two new funds will invest in proof of concept opportunities or where commercial returns may be low.

The Philanthropic Fund provides grants for academic research funded by other medical research charities and organisations.

The Seed Fund invests in promising early stage therapeutics and biological research.

The funds will be launched at the beginning of 2018 and further details on the application process will be disclosed nearer the time.  

Funding for MRC researchers

LifeArc operates the Development Gap Fund (DGF) on behalf of the MRC. DGF is a pre-seed translation fund available to scientists in MRC units and institutes. It provides funding to conduct translational research.

Projects might include:

• Proof of concept studies
• Target validation
• Aspects of drug discovery, such as assay development and tool generation, creation of antibodies and device or diagnostic prototyping.

For further information for MRC scientists, click here. 

For more information on the fund, click here.

If you’d like to discuss this opportunity further, please get in touch.